| Questcor shares jump on 2Q financial results - BusinessWeek |
|
|
BusinessWeek As a result, the company is expanding its nephrology selling effort, he added. Meanwhile, the company disclosed that it has identified that Acthar has a strong therapeutic and commercial potential as a treatment for systemic lupus erythematosus and |